# N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure

> **NCT00692718** · PHASE4 · UNKNOWN · sponsor: **Osaka General Medical Center** · enrollment: 160 (estimated)

## Conditions studied

- Acute Heart Failure
- Acute Myocardial Infarction

## Interventions

- **DRUG:** Epadel, Eicosapentaenoic acid

## Key facts

- **NCT ID:** NCT00692718
- **Lead sponsor:** Osaka General Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-07
- **Primary completion:** 2010-06
- **Final completion:** —
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2008-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00692718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00692718, "N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00692718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*